Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltdverified

TLSA

Price:

$1.1064

Market Cap:

$114.06M

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL...[Read more]

Industry

Biotechnology

IPO Date

2018-11-20

Stock Exchange

NASDAQ

Ticker

TLSA

The Enterprise Value as of September 2024 (TTM) for Tiziana Life Sciences Ltd (TLSA) is 113.12M

According to Tiziana Life Sciences Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 113.12M. This represents a change of 1.18% compared to the average of 8.85M of the last 4 quarters.

Tiziana Life Sciences Ltd (TLSA) Historical Enterprise Value (quarterly & annually)

How has TLSA Enterprise Value performed in the past?

The mean historical Enterprise Value of Tiziana Life Sciences Ltd over the last ten years is 224.38M. The current 113.12M Enterprise Value has changed 4.94% with respect to the historical average. Over the past ten years (40 quarters), TLSA's Enterprise Value was at its highest in in the June 2020 quarter at 303.55M. The Enterprise Value was at its lowest in in the December 2021 quarter at -42186000.00.

Quarterly (TTM)
Annual

Average

224.38M

Median

146.01M

Minimum

-936000.00

Maximum

627.52M

Tiziana Life Sciences Ltd (TLSA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tiziana Life Sciences Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 322.53%

Maximum Annual Enterprise Value = 627.52M

Minimum Annual Increase = -102.17%

Minimum Annual Enterprise Value = -936000.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-936000.00-102.17%
202243.16M-18.85%
202153.18M-80.76%
2020276.36M86.70%
2019148.02M2.79%
2018144.01M-56.24%
2017329.07M-47.56%
2016627.52M24.47%
2015504.15M322.53%
2014119.32M-95.67%

Tiziana Life Sciences Ltd (TLSA) Average Enterprise Value

How has TLSA Enterprise Value performed in the past?

The current Enterprise Value of Tiziana Life Sciences Ltd (TLSA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

31.80M

5-year avg

103.96M

10-year avg

224.38M

Tiziana Life Sciences Ltd (TLSA) Enterprise Value vs. Peers

How is TLSA’s Enterprise Value compared to its peers?

Tiziana Life Sciences Ltd’s Enterprise Value is less than Clearmind Medicine Inc. (0), greater than Hillstream BioPharma, Inc. (-3073256.00), greater than Coeptis Therapeutics, Inc. (1.48M), greater than Magenta Therapeutics, Inc. (7.58M), greater than Quoin Pharmaceuticals, Ltd. (-114170976.00), greater than Affimed N.V. (-556254.00), greater than Leap Therapeutics, Inc. (57.77M), greater than Adaptimmune Therapeutics plc (30.67M), greater than Corvus Pharmaceuticals, Inc. (93.80M), less than Aptose Biosciences Inc. (336.77M), greater than Bionomics Limited (-267138.00), greater than Accustem Sciences Inc. (-1547828.00), greater than Comera Life Sciences Holdings, Inc. (-71010.00), greater than SciSparc Ltd. (-913895.00), greater than Biohaven Pharmaceutical Holding Company Ltd. (-1381116.00), less than Immunome, Inc. (3.61B), less than Inhibrx, Inc. (755.67M), greater than AgeX Therapeutics, Inc. (28.49M), greater than Icosavax, Inc. (19.70M), less than null (713.87M),

Build a custom stock screener for Tiziana Life Sciences Ltd (TLSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tiziana Life Sciences Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tiziana Life Sciences Ltd (TLSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tiziana Life Sciences Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tiziana Life Sciences Ltd's Enterprise Value?

What is the highest Enterprise Value for Tiziana Life Sciences Ltd (TLSA)?

What is the 3-year average Enterprise Value for Tiziana Life Sciences Ltd (TLSA)?

What is the 5-year average Enterprise Value for Tiziana Life Sciences Ltd (TLSA)?

How does the current Enterprise Value for Tiziana Life Sciences Ltd (TLSA) compare to its historical average?